Literature DB >> 16049282

Granulomatous reactions cause symptoms or clinically imitate treatment resistance in small lymphocytic lymphoma/chronic lymphocytic leukaemia more frequently than in other non-Hodgkin lymphomas.

A Brunner1, J Kantner, A Tzankov.   

Abstract

AIMS: The electronic database of the institute of pathology, Medical University of Innsbruck, was reviewed and patient histories studied to analyse systematically the coincidence of granulomatous reactions and lymphomas in a large patient collective, and to find distinct clinicopathological correlations. Five cases of small lymphocytic lymphoma/chronic lymphocytic leukaemia (CLL) associated with granulomatous reactions in lymph nodes and bone marrow were identified, all clinically associated with signs of progressive disease.
METHODS: Cases were acquired by reviewing an electronic database comprising approximately 715,000 patients diagnosed between 1993 and 2003. Histochemical, immunohistochemical, and molecular techniques were used to verify diagnosis and associated infectious diseases. Clinical data were obtained from reviewing the charts.
RESULTS: Of 2044 bone marrow and 411 lymph node non-Hodgkin lymphoma biopsy samples, CLL was most frequently associated with bone marrow (two cases) and lymph node granulomas (three cases). These granulomas were mostly composed of epithelioid cells, with or without giant cells, and in all but one case did not show necrosis. All patients with CLL had clinical symptoms primarily caused by the granulomatous disease: two suffered from acid fast bacilli infections (Mycobacterium tuberculosis and mycobacteria other than tuberculosis) and three presented with clinical manifestations of sarcoidosis (the reason a diagnostic biopsy was performed).
CONCLUSIONS: Granulomatous reactions in patients with CLL might obscure diagnosis and imitate disease progression and Richter's transformation. Careful histological examination, exclusion of infectious agents, and a detailed clinical history are essential for correct diagnosis.

Entities:  

Mesh:

Year:  2005        PMID: 16049282      PMCID: PMC1770862          DOI: 10.1136/jcp.2004.023911

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  31 in total

1.  Association between chronic lymphocytic leukemia and sarcoidosis: clinical value of bronchoalveolar lavage.

Authors:  A Marruchella; R Epis; G Camerone; M Tondini
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1999-03       Impact factor: 0.670

2.  The significance of granulomatous lesions in bone marrow aspirations.

Authors:  G L PEASE
Journal:  Am J Clin Pathol       Date:  1952-02       Impact factor: 2.493

3.  Interferon-alpha therapy associated with the development of sarcoidosis.

Authors:  A Pietropaoli; J Modrak; M Utell
Journal:  Chest       Date:  1999-08       Impact factor: 9.410

4.  Cutaneous sarcoidosis in a patient with Philadelphia-positive chronic myelogenous leukemia treated with interferon-alpha.

Authors:  L L Yavorkovsky; G Carrum; S Bruce; P L McCarthy
Journal:  Am J Hematol       Date:  1998-05       Impact factor: 10.047

Review 5.  Bone marrow granulomas: clinicopathologic findings in 72 cases and review of the literature.

Authors:  V Bhargava; D C Farhi
Journal:  Hematol Pathol       Date:  1988

Review 6.  Systemic sarcoidosis and cutaneous lymphoma: is the association fortuitous?

Authors:  M Schmuth; C Prior; B Illersperger; G Topar; P Fritsch; N Sepp
Journal:  Br J Dermatol       Date:  1999-05       Impact factor: 9.302

7.  Small noncleaved cell lymphoma associated with florid epithelioid granulomatous response. A clinicopathologic study of seven patients.

Authors:  H C Hollingsworth; D L Longo; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1993-01       Impact factor: 6.394

8.  Sarcoidosis induced by interferon therapy for chronic myelogenous leukaemia.

Authors:  M Kikawada; Y Ichinose; A Kunisawa; N Yanagisawa; K Minemura; I Kasuga; M Yonemaru; K Kawanishi; M Takasaki; K Toyama
Journal:  Respirology       Date:  1998-03       Impact factor: 6.424

9.  Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survival.

Authors:  C M Spier; S M Lippman; T P Miller; T M Grogan
Journal:  Cancer       Date:  1988-02-01       Impact factor: 6.860

10.  The sarcoidosis-lymphoma syndrome.

Authors:  H Brincker
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

View more
  7 in total

1.  Gastric sarcoidosis in the setting of chronic lymphocytic leukemia.

Authors:  George A Holman; Kevin M Kolendich
Journal:  Dig Dis Sci       Date:  2013-12-20       Impact factor: 3.199

2.  [Rupture of the spleen. Clinicopathological correlations and diagnostic procedures].

Authors:  A Tzankov; H Adams; W Sterlacci
Journal:  Pathologe       Date:  2008-03       Impact factor: 1.011

Review 3.  [Normal bone marrow and common reactive alterations].

Authors:  A Tzankov; S Dirnhofer; C Beham-Schmid
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 4.  [Non-neoplastic lesions of the mediastinum].

Authors:  A Tzankov
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

5.  A case with coincidental diagnosis of primary central nervous system lymphoma and lymph node sarcoidosis.

Authors:  Eva J Greiner; Lars-Olof Mügge; Bernd F M Romeike; Theodoros Topalidis; Bernhard Theis; Andreas Ragoschke-Schumm; Otto W Witte; Albrecht Günther
Journal:  J Neurooncol       Date:  2010-01-07       Impact factor: 4.130

6.  The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia / small lymphocytic lymphoma: a 25-year multicenter experience.

Authors:  Anne-Laure Poitou-Verkinder; Arnaud Francois; Fanny Drieux; Stéphane Lepretre; Bruno Legallicier; Bruno Moulin; Michel Godin; Dominique Guerrot
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

Review 7.  Psoas Abscess Due to Mycobacterium avium in A Patient with Chronic Lymphocytic Leukemia-Case Report and Review.

Authors:  Natascha D Diaco; Bettina Strohdach; Anna L Falkowski; Nicolin Hainc; Philippe Brunner; Jonas Rutishauser; Lorenz Jost; Philip E Tarr
Journal:  J Clin Med       Date:  2019-02-07       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.